Skip to main content
Caplight Logo









Capsigen

Capsigen

Private
Vancouver, WashingtonHealthcare & Life Scienceshttps://capsigen.com/

Last Round

Accelerator

Jul 12, 2023

Total Funding Raised

$15M

Momentum

Top 50%

of companies Caplight tracks

Company Overview

Capsigen is a biotechnology company that engineers custom adeno-associated virus (AAV) capsids to deliver gene therapies for central nervous system and neuromuscular disorders.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Precision Medicine

Business Model

B2B

Customer Profile

Services & Consulting, Revenue Share

AI Layer

Application

Keywords

AAV capsid engineeringgene therapy deliveryviral vectorsdirected evolutionadeno-associated virusAAVbiotech R&Ddrug delivery platformcapsid screeningbiotech discoveryprecision medicinebio-pharma partnershipsynthetic biologyvector engineeringgene delivery tech

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Capsigen Comparables

Compare Capsigen with similar companies based on industry and business-model similarity.

Capsigen comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
AAVnerGene Inc.
84%
Shape Therapeutics
83%
Apertura Gene Therapy
83%

Capsigen Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
AcceleratorJul 12, 2023
StrategicMay 10, 2021

Capsigen Investors

Notable investors and investment history

Capsigen investors
InvestorRounds
Creative Destruction LabAccelerator

Market signals

Structured signals derived from secondary market and firmographic data.

  • May 14, 2026

    Monthly visitors increased 37% MoM.

  • Jul 12, 2023

    Received funding from Creative Destruction Lab.

Capsigen Filings

Explore SEC and related filing metadata, where available.

Capsigen filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Capsigen's valuation, stock price, and market status.

Is Capsigen a public or private company?

Capsigen is a private company.

What is the current stock price of Capsigen?

Capsigen is a private company with no public stock price. No recent secondary market data is available.

How much is Capsigen worth (valuation)?

Valuation information for Capsigen is not publicly available.

Can I buy Capsigen stock?

Capsigen shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Capsigen's last funding round?

Capsigen's most recent funding round was Accelerator on July 12, 2023.

Who are the main investors in Capsigen?

Key investors in Capsigen include Creative Destruction Lab.

Will Capsigen IPO soon?

No public IPO plans have been announced for Capsigen.

How can I track Capsigen secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Capsigen's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersVancouver, Washington
Employee Range3
Year Founded2020
Last FundingJul 12, 2023

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?